Institute begins Phase III TB vaccine clinical trial in South Africa

The Bill & Melinda Gates Medical Research Institute (Gates MRI) has commenced a phase III clinical trial to assess the efficacy of the M72/AS01E tuberculosis (TB) vaccine candidates with first doses in South Africa.